Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. cancerscreen

CANCERSCREEN SIGNED

Screening for cancer in the post-genomic era: diagnostic innovation and biomedicalisation in comparative perspective

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CANCERSCREEN project word cloud

Explore the words cloud of the CANCERSCREEN project. It provides you a very rough idea of what is the project "CANCERSCREEN" about.

tests    health    interactions    sickness    private    innovation    biomedicine    anecdote    freight    conceptual    opinion    day    literature    human    diagnostic    domain    monopolies    scholarship    data    transnational    diagnostics    examine    revolution    surrounding    deliberation    alia    qualitative    empirical    innovative    public    paucity    detection    linking    quantitative    dimensions    investments    insights    transition    first    decade    decision    industry    economy    steer    theory    map    actors    risks    generation    genome    trajectories    political    socio    technological    expectations    integration    screening    biomedicalisation    patenting    technologies    regime    regulatory    expert    combining    dynamics    shaping    gene    reconfiguring    harms    molecular    regulation    age    usa    boundaries    disease    genomic    redrawing    categories    fuel    continue    policy    1996    model    platform    accompanied    unprecedented    inter    cancer    scientometric    integrative   

Project "CANCERSCREEN" data sheet

The following table provides information about the project.

Coordinator		 THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE 

Organization address
address: TRINITY LANE THE OLD SCHOOLS
city: CAMBRIDGE
postcode: CB2 1TN
website: www.cam.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Total cost 1˙347˙992 €
 EC max contribution 1˙347˙992 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) coordinator 1˙047˙674.00
2    THE UNIVERSITY OF SUSSEX UK (BRIGHTON) participant 300˙317.00

Map

 Project objective

Cancer screening and the diagnostics industry: a comparative analysis of the political economy of diagnostic innovation A decade after the Human Genome Project, major public and private investments continue to fuel expectations of a genomic revolution in biomedicine. The freight of expectations surrounding the new “age of diagnostics” is accompanied by much uncertainty about how public policy should steer diagnostic innovation, with much debate about inter alia the harms of creating diagnostic monopolies through gene patenting, and the risks of under- or over-regulation. However, due to the paucity of research on diagnostic innovation, policy deliberation is driven more by anecdote and expert opinion than empirical evidence. With a specific focus on screening/early detection of cancer, this project will map industry dynamics, technological trajectories and regulatory developments in Europe and the USA from 1996 to the present day. Combining quantitative and qualitative methods, the project’s innovative dimensions include a new conceptual model of socio-technical transition in the diagnostics sector, and the first integrative analysis linking scientometric data on the interactions between public and private actors in the diagnostic research domain with comparative transnational analysis of regulatory decision-making. Through a novel integration of conceptual insights from the literature on biomedicalisation and scholarship on socio-technical regime change, this project aims to advance both fields of research by applying a new multi-scale, multi-level model of socio-technical transition. The project will provide unprecedented insight into the factors shaping the development of a new generation of molecular diagnostic tests, and examine how these technologies are reconfiguring disease categories and redrawing the boundaries between health and sickness. We will establish a platform of theory and methods for a broader programme of work on diagnostic innovation.

 Publications

year authors and title journal last update
List of publications.
2019 Kelly Holloway, Fiona A Miller, Alberto Gutierrez, Stuart Hogarth
Dangerous diagnostics? Regulatory reform in the genomic era
published pages: l640, ISSN: 0959-8138, DOI: 10.1136/bmj.l640 		BMJ 2020-01-30
2019 Kelly Holloway, Fiona A. Miller, François Rousseau, Alberto Gutierrez, Stuart Hogarth
Health Canada needs to act on laboratory-developed diagnostics
published pages: E1067-E1069, ISSN: 0820-3946, DOI: 10.1503/cmaj.190550 		Canadian Medical Association Journal 191/39 2020-01-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCERSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CANCERSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

Cu4Peroxide (2020)

The electrochemical synthesis of hydrogen peroxide

Read More  

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More  

SPECTRODOT (2018)

Hand-held broadband hybrid graphene-quantum dots spectrometer

Read More